Cholesterol Medication Recall Alert

Federal health authorities have announced the recall of over 140,000 bottles of cholesterol medication due to issues with “defective dissolution specifications.”

The Food and Drug Administration (FDA) indicated in a recent enforcement report that atorvastatin calcium tablets, which are prescribed to manage cholesterol and prevent heart-related conditions, are among those affected. This drug is the generic form of Lipitor and belongs to a class of medications known as statins. Essentially, it works by inhibiting an enzyme in the liver responsible for cholesterol production.

When a drug doesn’t meet dissolution specifications, it suggests it hasn’t dissolved as expected according to clinical testing standards. This can be a real concern—if the tablets aren’t dissolving correctly, they might not effectively lower cholesterol levels.

According to the FDA’s guidelines, this recall is classified as Class II. This category applies when exposure to the product could lead to temporary health issues or effects that could be medically reversible but are not likely to result in severe health problems.

The pharmaceutical company behind these tablets, Alkem Laboratories, distributed them via Ascend Laboratories LLC. The recall affects eight specific lot numbers, which have expiration dates from July 2026 to February 2027.

Many of these bottles come in sizes of 90, 500, and 1,000 tablets.

Currently, FOX Business has reached out for comments from both Alkem Laboratories and Ascend Laboratories regarding this issue.